Electrolytic lesions in the anterior and mid-diencephalon and ventral midbrain in guinea pigs were produced to examine the effects of interruption of the fornix (FX), mammillothalamic tracts (MT), and mammillary peduncles (MP), respectively, on the expression of pentylenetetrazol (PTZ) seizures. As a group, all mid-diencephalic lesioned animals had some degree of protection from the electroencephalographic and behavioral convulsant and lethal effects of the drug. Through a composite volume analysis of protected versus unprotected animals, as well as a retrospective comparison between MT and non-MT lesioned animals, it was demonstrated that small mid-diencephalic lesions incorporating only the MTs and their immediate vicinity were capable of completely preventing the convulsant and lethal effects of PTZ. Lesions of the FX and MP were also protective against PTZ seizures but to a lesser degree than the MT lesions.
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These results demonstrate that the major afferent and efferent connections of the mammillary bodies are involved in expressing PTZ seizure activity and suggest that the MT may be the major pathway mediating paroxysmal activity from brain stem to the thalamus.
The expression of generalized seizures is characterized by bilateral and synchronous activation of cortical and subcortical brain regions. Although the functional anatomy of this convulsive process is yet unclear, substantial evidence suggests that subcortical brain regions, through their widespread cortical connections, play a major role in the propagation and perhaps initiation of these attacks. Early studies demonstrated numerous facilitatory and inhibitory influences on seizure activity in both the brain stem and diencephalon (Morison and Dempsey, 1942; Jasper and Droogleever-Fortuyn, 1946; Hunter and Jasper, 1949; Ingvar, 1955a, b; Ralston and Ajmone-Marsan, 1956; Kriendler et al., 1958; Andy and Mukawa, 1959; Bergman et al., 1963; Guerrero-Figueroa et al., 1963; Weir, 1964) and suggested important roles for diffusely organized regions such as the reticular formations of the pons, mesencephalon, and thalamus. Specific areas of the subcortex have also been associated with seizure mechanisms, including the hypothalamus (Murphy and Gellhorn, 1945; Jasper and Droogleever-Fortuyn, 1946; Green and Morin, 1953; Gellhorn et al., 1959) fields of Fore1 (Jinnai, 1966; Jinnai et al., 1969; Jinnai and Mukawa, 1970) , substantia nigra (Iadarola and Gale, 1982; Garant and Gale, 1983; Gonzalez and Hettinger, 1984; McNamara et al., 1983 McNamara et al., , 1984 , and several thalamic nuclei (Mullen et al., 1967; Jinnai et al., 1969; Feeney and Gullotta, 1972; Kusske et al., 1972; Van Straaten, 1975; Quesney et al., 1977) .
Recently we observed the selective metabolic activation of the mammillary bodies (MB) and their immediate connections during a threshold convulsive stimulus induced by the co-infusion of pentylenetetrazol (PTZ) and ethosuximide (ESM) (Mirski and Ferrendelli, 1983) . We also reported preliminary data demonstrating that the interruption of the mammillothalamic tracts (MT), bilaterally, had a substantial protective effect against the convulsant PTZ ( Mirski and Ferrendelli, 1984a, b) . In the present report we examined in detail the effects of interruption of both afferent and efferent connections of the MB on PTZ-induced seizures.
Materials and Methods
Lesions. Lesions were directed towards the interruption of the major connections of the MB and of destruction of the nuclear complex itself. However, apparently because of its ventral location at the base of the brain, large lesions required to ablate the MB were accompanied by a high incidence of severe brain hemorrhage, resulting in substantial animal morbidity and mortality. In light ofthese effects, direct MB ablation was not pursued.
Female albino guinea pigs (250-300 gm, Isaacs), anesthetized with a 4% halothane (Fluothane, Ayerst) in 02, were placed in a rat stereotaxic frame (Kopf) equipped with a guinea pig adapter. Electrolytic lesioning was performed using a stainless steel electrode, 250 pm diameter with a 100 pm exposed tip, attached to a DC constant-current lesion maker (Grass). Current ranged from 0.5 to 1.5 mA with a pulse time of 5-30 sec. Following surgery, the scalp was sutured, and the animals were allowed to recover 1 week prior to testing. Mortality from the operative procedure was <5%, and no abnormal behavior was noted following the surgery in most animals. Animals that experienced substantial motor impairment or feeding abnormality accompanied by weight loss were discarded from the study (< 5OYo). Lesion coordinates with the incisor bar set at -10.0 were the following: Fomix, 1.6 mm posterior to Bregma (AP), 1.2 mm lateral to the superior sag&al suture (L), and 9.0 mm ventral to cortical surface (H); Mammillothalamic tracts, 2.6 mm AP, 1.2 mm L, and 8.2 mm H; Mammillary peduncles, 4.7 mm AP, 1.0 mm L, and 10.7 mm H.
Behavioral testing. Experiments on mortality and behavior after administration of PTZ were performed using intraperitoneal injections of the convulsant (50 mg/ml) dissolved in saline. Clinical behavior following PTZ was observed and scored as follows: 0, no seizure; 1, mild clonic; 2, severe clonic (explosive motor activity); 3, severe clonic within the first 10 mitt; 4, severe recurrent clonics; 5, steady clonic with the animal on its side; 6, same as 5 but within the first 10 min. Animals tested more than once with PTZ were allowed a 4-5 d recovery period between challenges with the convulsant. Electroencephalographic (EEG) recording. Animals were lightly anesthetized with halothane, tracheotomized, and paralyzed with 50 mg/kg Plaxedil (gallamine triethiodide, Davis & Geck). A 1% solution of procaine HCl (Novocain, Breon) was immediately applied to all wound margins, and the animals were ventilated with a N,O/O, mixture, the ratio of which was adjusted around 65%/35% to keep the arterial PO, above 100 mg Hg. The arterial Pco, was kept at approximately 35 mm Hg by adjustment of the ventilation rate. The arterial pH was thus kept approximately 7.40 ? 0.05. The body temperature was maintained at 37.0 l?r. 0.5"C by a heating apparatus. A femoral artery was cannulated for blood pressure and blood gas monitoring. The skull was exposed and 4 stainless steel electrodes were placed in the parietal bones, 2 on each side of the sagittal suture, approximately 2 mm lateral to it and 6 mm apart from the ipsilateral electrode.
Theblood pressure was continuously monitored, and the animal was rejected if it fell significantly below normal (76/48 mm Hg). The EEG was recorded on a Grass model 7D polygraph.
The EEG was recorded for 1 hr after the injection of PTZ, and the expression of repetitive high-voltage synchrony was quantified. After beina tested. the animals were sacrificed and their brains fixed in 10% fort&in, &bedded in paraffin, sectioned, and stained for histological examination. Locating the lesions was done without knowledge of the previous response of the animal to PTZ.
Results

Control animals
Examination of control, unlesioned animals treated with PTZ revealed that the threshold for clonic seizure activity was 50 mg/kg, and this dosage resulted in no fatalities. Both 75 and 100 mg/kg PTZ induced severe clinical seizures, beginning approximately 90 and 45 set, respectively, following injection. The onset of the convulsions was characterized by repetitive myoclonic jerks, forepaw retraction, and torsion of the head. This relatively minor seizure activity was followed by explosive uncontrollable running and/or recurrent clonic seizures. Tonic seizures occurred in many animals, but classic full tonic extension of hindlimb or forelimb was rarely observed. Tabulated mean seizure scores for the control animals approached the maximum possible of 6 at 75 mg/kg PTZ, and all controls had a maximum score at 100 mg/kg (Fig. IA) . A dose of 75 mg/kg of the convulsant was lethal in 81% (LD,,) of the animals, and 100 mg/ kg was lethal in 100% (LD,,,) (Fig. 1B) .
Control guinea pigs were also examined electroencephalographically, under paralyzed and ventilated conditions, to monitor the effects of PTZ on cortical electrical activity. Because 100 mg/kg of the convulsant resulted in variable EEG responses in control animals, 150 mg/kg, a supermaximal dose, was administered in this study. This dose in control animals reliably produced repetitive hypersynchronous seizure discharges on EEG that occupied slightly more than 50% of the recording time (Fig. 10 Mammillothalamic tract (MT) lesions
Guinea pigs with lesions in the mid-diencephalon, roughly that portion traversed by the MT, were challenged with injections of PTZ. A total of 83 bilaterally lesioned animals were examined, as well as 10 animals with unilateral lesions. The response to administration of 50 mg/kg PTZ in all lesioned guinea pigs was similar to the observed effects in control animals; i.e., no convulsions or only minor clonic activity. The injection of 75 mg/kg to the mid-diencephalic lesioned animals resulted in a broad spectrum of seizure severity. Of the 83 bilaterally lesioned animals tested at 75 mg/kg PTZ, 28 (33.7%) had no severe clonic activity (seizure score of 0 or 1) as compared to 6 of 114 (5.3%) control animals tested at that dose. This data is reflected in the mean seizure score (Fig. 1A) . The mortality rate at 75 mg/kg PTZ in the lesioned group was 60.2%, a decrease of 26% from that of controls. The animals that survived treatment with 75 mg/kg PTZ (n = 34) were then challenged with 100 mg/kg, the LD,,, dose in controls. Of these, 11 (13.3% of total) survived.
In addition, none of these survivors exhibited severe seizure activity, resulting in the significant difference in clinical seizure Figure 2 . Coronal brain sections of middiencephalon from anterior (top) to posterior (6otlom) with composites of bilateral middiencephalic lesions from guinea pigs: not surviving 75 mg/kg PI'2 challenge (light gray); surviving 75 mg@ PTZ without seizures but failing to survive 100 mg/kg of the convulsmt (dark gray); and surviving both 75 and 100 n&kg FTZ without behavioral seizures (hatched area). The MT is outlined scores at 100 &kg PTZ between control (6.0 ? 0.0) and the lesioned group (4.2 & 0.5). There was no significant protective effect observed in the unilaterally lesioned animals. Of the 10 animals tested, 9 died following 75 mg/kg PTZ. The surviving guinea pig also survived 100 mg/kg but had severe clonic sei-ZUIXS.
Mid-dimcephalic lesioned guinea pigs that survived both 75 and 100 me/kg PTZ challenrzes without severe behavioral seizure activity were examined'by EEG following 150 rag/kg of the convulsant. Eight animals were tested in this manner, and of these, 3 experienced no hypersynchmnous activity, the range for the remaining 5 was between 2 and 47% of the recording period. The mean for the 8 animals was 9.4%, a decrease of 82% from control. The single unilaterally lesioned survivor was also examined by EEG and hypwsynchronous activity accounted for 65% of the recording time (Fig. 10 .
In an effort to correlate the observed protective effect of the lesions with the neuroanatomical structures destroyed in the electrolytic process, composites of histologically determined lesion volumes were constructed. Figure 24 is a set ofcomposites of (I) all mid-diencephalic lesions; (2) lesions of animals protected at 75 mg/kg PTZ (seizure score of 0 or I) but not at 100 mg/kg; and (3) lesions of animals protected bath at 75 and 100 me/kg PTZ. Individual lesion size varied from 0.5 to 3.0 mm in diameter. The structures principally affected anteriorly by the lesions were the thalamus and subthalamic area. More posteriorly, the hypothalamus was increasingly incorporated into the ablated region, as were the posterior thalamus, subthalamus, and internal capsule.
Comparison of the composite volumes of lesions revealed that the portion of the diencephalon destroyed in animals pmtected against 75 mg/kg PTZ was smaller than that of the com- posite of all lesioned brain volumes. The composite volume of protective lesions was still further reduced when only lesions of guinea pigs protected from severe seizures at both 75 and 100 mg/kg PTZ were considered. Structures incorporated within this boundary included only portions of both anterior and ventral thalamus, the subthalamic region including the MT, and dorsal parts of the hypothalamus (Fig. 2A) . Lesions in this group ranged from 0.5 mm to no more than 1.5 mm in diameter.
A retrospective analysis was also performed examining the effects of interruption of the MT on PTZ-induced seizures. Lesions were accordingly divided into 3 groups: (1) complete bilateral interruption of the MT (n = 38); (2) partial interruption of the MT, bilaterally or unilaterally (n = 2 1); and (3) no interruption of the tracts bilaterally (n = 24). Both mortality and clinical seizure score were assessed in each group (Fig. 3) .
Animals with lesions not involving the MT did not differ from controls with respect to either mortality or behavioral seizure activity. No lesions avoiding the MT resulted in protection at 100 mg/kg, and only 2 prevented seizures at 75 mg/ kg PTZ. Analyzed as a group, all lesions completely interrupting the MT bilaterally were very protective, decreasing the seizure score by 38% at 75 mg/kg and 33% at 100 mg/kg PTZ, however, the degree of protection was dependent on lesion size (see below). A parallel reduction in mortality was also noted: 20 of 38 (53%) MT lesioned animals survived 75 mg/kg PTZ (compared with 19% in controls) and 7 of 38 (18%) survived the control LD,, dose. Of the 8 animals analyzed by EEG, 5 had complete MT lesions and 3 had partial lesions. EEG seizure activity in each subgroup was significantly reduced from control (Fig. 3C') .
Of interest in this study, bilateral lesions resulting in partial MT interruption were as protective as those completely interrupting the tracts. Unilaterally lesioned animals, however, were not protected regardless of the type of lesion. Of the 10 guinea pigs with unilateral lesions, 3 were complete MT lesions, 4 were partial MT lesions, and the remaining 3 were complete misses. The survivor of 75 and 100 mg/kg PTZ (seizure score of 0 and 4, respectively) had a partial MT lesion. Composites of the complete and partial MT lesion groups, as well as lesions that did not affect the MTs, were also constructed and analyzed by dividing the lesions according to their degree of protection against 7 5 or 7 5 and 100 mg/kg of the convulsant ( Fig. 2, C, D) . It was readily apparent from this analysis that there was an inverse correlation between lesion size and protective effect, i.e., the more protective the lesion, the smaller the size of the ablated area (Fig. 28) . The smallest lesions, 0% 1 mm, which were essentially limited to the immediate area adjacent to and including the MT, completely protected against the convulsant and lethal effects of PTZ. Slightly larger lesions, 1 .O-1.5 mm, were partially protective, and the largest, > 1.5 mm, were not protective. A similar correlation was noted in the partial MT lesions, the most protective of which were very small and adjacent to the MT (Fig. 2C) . Lesions in animals that survived 75 mg/kg PTZ with no clinical seizures and without complete or partial interruption of the MT (n = 2) were found to be very small and just dorsal to the 2 tracts (Fig. 20) . seizure score of 1.6 f 0.6 and 0.9 + 0.3 in the FX and MP lesioned guinea pigs, respectively (Fig. 6A ). These significantly attenuated responses were specific for lesions interrupting the tracts. At this dose, lesions of either pathway resulted in a significant concomitant reduction in mortality, from an LD,, to an LD,, (FX) and LD, (MP) (Fig. 6B) . At 100 mg/kg PTZ, however, no significant protective effect was observed. Only 1 of 5 FX-lesioned and 1 of 13 MP-lesioned animals tested at that dose survived. In contrast to the MTlesioned animals, several FX-lesioned guinea pigs completely protected from behavioral seizure activity at 75 mg/kg PTZ were not tested at 100 mg/kg but were examined electroencephalographically with injection of 150 mg/kg of the convulsant. The 3 animals tested in this manner experienced repetitive hypersynchronous cortical discharges for a mean of 2.1 + 1.8% of the recording period, as compared with the control value of 51.8 + 8.3%.
Discussion
The results of this study demonstrate that lesions in the diencephalon and ventral midbrain may be highly protective against the convulsant action of PTZ. Selected lesions not only blocked the clinical convulsant activity and lethal effect of the drug but also prevented electrical seizure discharges. However, results clearly indicate that both the size and the location of the brain l Protection Against PTZ Seizures lesions are important determinants of the anticonvulsant effect. 1969). In that study, bilateral lesions in the MB resulted in an In our composite volume analysis we observed that discrete almost 2-fold increase in PTZ seizure threshold. Inadvertent lesions in the mid-diencephalon damaging the MT were the interruption of the MT has also been described in several case most protective. Previous observations in our laboratory using studies of epileptic patients successfully treated surgically (Mul-14C-2-deoxyglucose autoradiography had implicated the MT in len et al., 1967) . Finally, fomicotomies have been reported to seizure mechanisms (Mirski and Ferrendelli, 1983) . We are be effective in the alleviation of several varieties of seizures in therefore of the opinion that interruption of this connection humans, including generalized epilepsy (Orthner and Lohman, 1966; Schaltenbrand et al., 1966) . between the mammillary bodies and anterior thalamus is a major factor in the observed anticonvulsant effect. In support of this hypothesis are the facts that no lesion that completely missed the MT was protective at 100 mg/kg PTZ and that all protective partial MT lesions visibly destroyed only small regions of adjacent brain tissue. Of course we cannot fully exclude the possibility that nearby structures such as the subthalamic region or ventral thalamus have a role in the protective effect of the lesions.
Lesions involving the FX or MP were similarly demonstrated to result in a significant increase in threshold to the convulsant PTZ. By comparing lesioned and non-lesioned FX or MP composite volumes, the association between the protective effect of the lesions and the interruption of the 2 major afferents to the MB was strengthened. That both afferent and efferent MB pathways have a facilitatory influence on PTZ seizures strongly supports the concept that this hypothalamic nucleus has an important role in the expression of generalized seizures.
Most neurons in the medial mammillary bodies have bipolar axons that send processes rostrally to the anterior nucleus of the thalamus via the MT and caudally to the dorsal and ventral tegmental nuclei of the brain stem via the mammillotegmental tract (Cowan et al., 1964; Cruce, 1975 Cruce, , 1977 Van der Kooy et al., 1978; Veazey et al., 1982a, b) . Reciprocal connections from the tegmental nuclei to the MB project anteriorly in the MP. This pathway between the upper brain stem and the anterior thalamus was first referred to by Nauta as the "thalamiomidbrain circuit" (Nauta, 1958) . Our previous observation of selective metabolic activation of this circuit by a threshold convulsant stimulus was the first indication that it is involved in the expression of generalized seizures. That interruption of the MT or MP prevents PTZ seizures indeed suggests that this systern may, in part, mediate the convulsive action of PTZ between the thalamus and brain stem.
The involvement of the MB and its connections in seizure mechanisms is supported by several lesion studies by other investigators. The anterior thalamus, for example, has been associated with the expression of both focal and generalized convulsant activity. Kusske et al. (1972) reported that lesions of ventral anterior thalamus decreased seizure frequency and duration in experimental models of focal cortical epilepsy, thereby preventing the generalization of the seizures. Similarly, Feeney and Gullotta (1972) demonstrated marked suppression of seizure discharges by lesions of the rostra1 thalamus. Marked depression of the responsiveness of centrum medianum cells was observed following rostral thalamic lesion, suggesting that the rostral thalamus may exert tonic control over other thalamic nuclei (Feeney et al., 1970) . Stereotaxic lesion of anterior thalamus has also been clinically successful in the treatment of partial and generalized epilepsy (Spiegel et al., 195 1; Mullen et al., 1967) .
It was observed during the composite analysis of lesions in the mid-diencephalon that the most protective lesions were those that damaged the MT and only very small portions of adjacent brain tissue. Indeed, large lesions involving the MT were not protective. Although seemingly paradoxical, this observation can be understood in light of the accumulated evidence demonstrating both facilitatory and inhibitory influences in the diencephalon on the expression of seizures (Andy and Mukawa, 1959; Gellhom et al., 1959; Milhorat et al., 1966; Jinnai et al., 1969; Gloor et al., 1977; Quesney et al., 1977) . The failure of such large ablations to attenuate the PTZ convulsions suggests that destruction of other neuronal structures near the MT has an opposite, facilitatory effect on the expression of generalized seizures. This observation that large and small diencephalic lesions incorporating the same regions of brain may have opposite effects on seizure theshold has, in fact, been previously reported (Milhorat et al., 1966; Mullen et al., 1967) . In our middiencephalic lesion experiments, the volume difference between the composite of all MT lesions and of the most protective MT lesions yields a region of brain that may be presumed to include a powerful inhibitory influence on seizure expression. Within this volume are several structures-such as the thalamic ventrolateral and centromedian nuclei, anterior hypothalamus, and dorsorostral midbrain-that have been previously associated with inhibition of paroxysmal activity (Milhorat et al., 1966; Jinnai et al., 1969) . The severe limitation on the extent of the damaged area was not apparent in the FX lesions. Both small and large lesions in the anterior diencephalon interrupting the FX resulted in similar anticonvulsant effects. No correlation can be drawn from the MP lesion data either, as the ablated brain areas in these cases were all very discrete.
The anticonvulsant effect of FX and MP interruption suggests that neuronal activity between the hippocampus, brain stem, and MB also facilitates the expression of generalized seizures. Thus, the MB may serve to mediate convulsant activity between hippocampus, brain stem, and thalamus. This concept is supported by the observations of Green and Morin (1953) . Upon stimulation of various diencephalic structures, they reported the elicitation of "seizure-like activity" in the cerebral cortex only after stimulation in the diencephalon of the posterior hypothalamus, FX, MT, or anterior thalamus. Furthermore, the protective effect observed in the present study with bilateral MT lesions, as well as with lesions to either the FX or MP, suggests that the MT may be the final common pathway of propagation of paroxysmal activity to the thalamus and cortex from MBassociated subcortical structures.
Jinnai and colleagues, experimenting on cats, observed a significant increase in the threshold to PTZ following subcortical lesions, particularly in the mesencephalic reticular formation and the posterior, but not anterior, hypothalamus (Jinnai et al., Although the mechanisms involved in the initiation and propagation of generalized seizures is not entirely clear, experimental evidence supports the concept of an interactive process between cortical and subcortical influences in the generation of these attacks (Gloor, 1968; Gloor et al., 1977; Quesney et al., 1977) . It has been argued that cortical mechanisms, clearly important in the final expression of cortical seizure discharges and consequent evoked behavioral manifestations, may also have the primary role in eliciting generalized attacks (Ingvar, 1959; Bancaud, 197 1; Goldring, 1972; Mutani et al., 1973; Bancaud et al., 1974) . More recent evidence, however, has emphasized the role of the diencephalon and brain stem in the early events of seizure activity. As previously mentioned, structures such as the thalamic, mesencephalic, and pontine reticular formations, specific thalamic nuclei, hypothalamus and substantia nigra have been shown to mediate in some fashion the expression of various types of generalized seizures.
PTZ is a chemical convulsant that produces generalized seizures and is widely used as an experimental model for human petit ma1 epilepsy. Although its specific mechanism of action is not known, PTZ has been demonstrated to alter both neuronal membrane and synaptic properties (Eyzaguirre and Lilienthal, 1949; Bignami et al., 1966; DeRobertis et al., 1969; Prichard, 197 1; Gross and Woodbury, 1972; Pellmar and Wilson, 1977; Fowler and Partridge, 1984) . This convulsant has also been reported to be a selective antagonist of GABA (MacDonald and Barker, 1978) . Because human petit ma1 epilepsy and PTZinduced seizures are both selectively prevented by the anticonvulsant ethosuximide, it has been suggested that the epileptogenie mechanisms at either the cellular or systems level are similar.
Although PTZ exerts its effects throughout the CNS, the evidence suggests that subcortical mechanisms are important in the pathogenesis of generalized seizure produced by this drug. Especially intriguing are the experiments by Faingold (1977 Faingold ( , 1978a Faingold ( , b, 1980 , Velasco et al. (1975 Velasco et al. ( , 1976 , and Rodin et al. (1970) , which have established that the earliest detectable effects of PTZ on brain activity are found in the mesencephalic and rhombencephalic reticular formations, preceding subsequent evoked activity in other brain regions. The MB and its connections, by forming a thalamiomidbrain pathway, may be an important circuit in the functional anatomy involved in the propagation of PTZ generalized seizures. Possibly, this anatomical pathway may also mediate, in part, the expression of petit ma1 epilepsy in humans.
